Achromic superficial spreading melanoma accidentally treated with imiquimod.
نویسندگان
چکیده
© 2012 The Authors. doi: 10.2340/00015555-1166 Journal Compilation © 2012 Acta Dermato-Venereologica. ISSN 0001-5555 Imiquimod (AldaraTM, 3M Pharmaceuticals) is a member of the imidazoquinolone family of drugs. It is a topical treatment approved by the US Food and Drug Administration (FDA) for the treatment of external genital and perianal warts, non-hypertrophic actinic keratoses in immunocompetent individuals, and superficial basal cell carcinoma (1). Numerous off-label indications have been reported. Lately, imiquimod has been proposed for the treatment of superficial pigmented lesions, such as melanoma in situ and lentigo maligna (LM) (2).
منابع مشابه
CASE REPORT Superficial Spreading Basal Cell Carcinoma of the Face: A Surgical Challenge
OBJECTIVE We present the case of a white man with a facial nodule suspicious for basal cell carcinoma. METHODS Biopsy revealed clusters of basaloid tumor cells with peripheral palisading, consistent with a superficial spreading variant of basal cell carcinoma. RESULTS The patient was treated with Mohs micrographic surgery, with clear margins achieved after the second stage of excision. Howe...
متن کاملImmunomodulation by imiquimod in patients with high-risk primary melanoma
Imiquimod is a synthetic Toll-like receptor 7 (TLR7) agonist approved for the topical treatment of actinic keratoses, superficial basal cell carcinoma, and genital warts. Imiquimod leads to an 80-100% cure rate of lentigo maligna; however, studies of invasive melanoma are lacking. We conducted a pilot study to characterize the local, regional, and systemic immune responses induced by imiquimod ...
متن کاملMelanoma Arising after Imiquimod Use
Imiquimod belongs to the class of 1H-imidazo-[4,5-c]quinolones-drugs originally developed as nucleoside analogues with the aim of finding new potential antiviral agents (Harrison et al., 1988). Indeed, Imiquimod was first released as treatment for genital warts before its actions against skin cancer were studied. Imiquimod is a relatively small sized molecule (Mr = 240.3) and is hydrophobic, al...
متن کاملCutaneus cancers in elderly Medical treatment of actinic keratosis and superficial coutaneus cancers: imiquimod
Conclusions The treatment of certain non-melanoma coutaneous toumors with imiquimod 5% cream, has been effective, without collateral effects; erythema, edema, vesicles, crusts and erosions with itching or burning in the application area, have been the most frequent adverse events which however did not cause the suspension of therapy. A diligent and continuative follow-up is necessary. Published...
متن کاملDysplastic nevi in relation to superficial spreading melanoma.
The aim of the present study was to evaluate the frequency with which histologically confirmed dysplastic nevi are observed among patients with superficial spreading melanoma compared to patients with nodular melanoma. A pathology review of 117 new cases of first primary nonfamilial cutaneous melanoma identified 61 patients with superficial spreading melanoma and 19 with nodular melanoma. Study...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Acta dermato-venereologica
دوره 92 1 شماره
صفحات -
تاریخ انتشار 2012